
LINK . SPRINGER . COM {
}
Title:
Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer | Journal of Molecular Medicine
Description:
TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis upon binding to TRAIL receptors 1 and 2 (TRAIL-R1/DR4 and TRAIL-R2/DR5). TRAIL-R3 (DcR1) and TRAIL-R4 (DcR2) have no or only a truncated cytoplasmic death domain. Consequently, they cannot induce apoptosis and instead have been proposed to inhibit apoptosis induction by TRAIL. Agonists for the apoptosis-inducing TRAIL-R1 and TRAIL-R2 are currently tested in clinical trials. To determine the expression pattern of all surface-bound TRAIL receptors and their prognostic clinical value, we investigated tumour samples of 311 patients with breast cancer by immunohistochemistry. TRAIL receptor expression profiles were correlated with clinico-pathological data, disease-free survival and overall survival. TRAIL-R1 was more strongly expressed in better differentiated tumours, and correlated positively with surrogate markers of a better prognosis (hormone receptor status, Bcl-2, negative nodal status), but negatively with the expression of Her2/neu and the proliferation marker Ki67. In contrast, TRAIL-R2 and TRAIL-R4 expression correlated with higher tumour grades, higher Ki67 index, higher Her2/neu expression and a positive nodal status at the time of diagnosis, but with lower expression of Bcl-2. Thus, the TRAIL receptor expression pattern was predictive of nodal status. Patients with grade 1 and 2 tumours, who had TRAIL-R2 but no TRAIL-R1, showed a positive lymph node status in 47% of the cases. Vice versa, only 19% had a positive nodal status with high TRAIL-R1 but low TRAIL-R2. Most strikingly, TRAIL-R4 and -R2 expression negatively correlated with overall survival of breast cancer patients. Although TRAIL-R2 correlated with more aggressive tumour behaviour, mammary carcinoma could be sensitised to TRAIL-R2-induced apoptosis, suggesting that TRAIL-R2 might therefore be used to therapeutically target such tumours. Hence, determination of the TRAIL receptor expression profile may aid in defining which breast cancer patients have a higher risk of lymph node metastasis and worse overall survival and on the other hand will help to guide TRAIL-based tumour therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Health & Fitness
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don't see any clear sign of profit-making.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
pubmed, google, scholar, article, cancer, cas, breast, trail, trailr, expression, receptor, tumour, apoptosis, prognostic, apoptosisinducing, ligand, carcinoma, res, patients, ganten, receptors, walczak, death, human, sykora, koschny, clin, necrosis, survival, factorrelated, tnfrelated, status, access, cells, privacy, cookies, content, journal, domain, correlated, bcl, herneu, factor, hepatocellular, data, publish, research, search, medicine, significance,
Topics {✒️}
tnf-related apoptosis-inducing ligand month download article/chapter degli-esposti ma putative stem-cell subpopulation apoptosis-inducing trail-r1 induces cancer-specific apoptosis surface-bound trail receptors trail-r2-induced apoptosis node-negative breast cancer node-positive breast cancer related subjects cytotoxic ligand trail full article pdf cd95-mediated apoptosis trail-mediated apoptosis trail-induced apoptosis independent prognostic parameter investigated tumour samples higher tumour grades aggressive tumour behaviour nf-kappab pathway privacy choices/manage cookies apoptosis-mediating receptor higher her2/neu expression trail-r4 expression correlated apoptosis-promoting receptors human hepatocellular carcinoma invasive breast cancer pathological prognostic factors tumor epithelial cells adjuvant tamoxifen treatment inhibit apoptosis induction human breast cancer local growth promoter incomplete death domain breast cell lines van geelen cm van der wall trail receptor dr4 metastatic breast carcinoma human pancreatic cancer breast cancer tissue trail-r2/dr5 trail death receptors antitumour tumour effects molecular medicine aims situ ductal carcinoma hormone receptor status neoplastic breast tissues primary breast cancer
Schema {🗺️}
WebPage:
mainEntity:
headline:Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer
description:TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis upon binding to TRAIL receptors 1 and 2 (TRAIL-R1/DR4 and TRAIL-R2/DR5). TRAIL-R3 (DcR1) and TRAIL-R4 (DcR2) have no or only a truncated cytoplasmic death domain. Consequently, they cannot induce apoptosis and instead have been proposed to inhibit apoptosis induction by TRAIL. Agonists for the apoptosis-inducing TRAIL-R1 and TRAIL-R2 are currently tested in clinical trials. To determine the expression pattern of all surface-bound TRAIL receptors and their prognostic clinical value, we investigated tumour samples of 311 patients with breast cancer by immunohistochemistry. TRAIL receptor expression profiles were correlated with clinico-pathological data, disease-free survival and overall survival. TRAIL-R1 was more strongly expressed in better differentiated tumours, and correlated positively with surrogate markers of a better prognosis (hormone receptor status, Bcl-2, negative nodal status), but negatively with the expression of Her2/neu and the proliferation marker Ki67. In contrast, TRAIL-R2 and TRAIL-R4 expression correlated with higher tumour grades, higher Ki67 index, higher Her2/neu expression and a positive nodal status at the time of diagnosis, but with lower expression of Bcl-2. Thus, the TRAIL receptor expression pattern was predictive of nodal status. Patients with grade 1 and 2 tumours, who had TRAIL-R2 but no TRAIL-R1, showed a positive lymph node status in 47% of the cases. Vice versa, only 19% had a positive nodal status with high TRAIL-R1 but low TRAIL-R2. Most strikingly, TRAIL-R4 and -R2 expression negatively correlated with overall survival of breast cancer patients. Although TRAIL-R2 correlated with more aggressive tumour behaviour, mammary carcinoma could be sensitised to TRAIL-R2-induced apoptosis, suggesting that TRAIL-R2 might therefore be used to therapeutically target such tumours. Hence, determination of the TRAIL receptor expression profile may aid in defining which breast cancer patients have a higher risk of lymph node metastasis and worse overall survival and on the other hand will help to guide TRAIL-based tumour therapy.
datePublished:2009-08-13T00:00:00Z
dateModified:2009-08-13T00:00:00Z
pageStart:995
pageEnd:1007
sameAs:https://doi.org/10.1007/s00109-009-0510-z
keywords:
TRAIL receptor
Apoptosis
Prognosis
Breast cancer
Mammary carcinoma
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig6_HTML.gif
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:87
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Tom M. Ganten
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Jaromir Sykora
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ronald Koschny
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Emanuela Batke
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Sebastian Aulmann
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ulrich Mansmann
affiliation:
name:University of München
address:
name:Department of Medical Biometry and Epidemiology, University of München, München, Germany
type:PostalAddress
type:Organization
type:Person
name:Wolfgang Stremmel
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Hans-Peter Sinn
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Henning Walczak
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Imperial College London
address:
name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer
description:TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis upon binding to TRAIL receptors 1 and 2 (TRAIL-R1/DR4 and TRAIL-R2/DR5). TRAIL-R3 (DcR1) and TRAIL-R4 (DcR2) have no or only a truncated cytoplasmic death domain. Consequently, they cannot induce apoptosis and instead have been proposed to inhibit apoptosis induction by TRAIL. Agonists for the apoptosis-inducing TRAIL-R1 and TRAIL-R2 are currently tested in clinical trials. To determine the expression pattern of all surface-bound TRAIL receptors and their prognostic clinical value, we investigated tumour samples of 311 patients with breast cancer by immunohistochemistry. TRAIL receptor expression profiles were correlated with clinico-pathological data, disease-free survival and overall survival. TRAIL-R1 was more strongly expressed in better differentiated tumours, and correlated positively with surrogate markers of a better prognosis (hormone receptor status, Bcl-2, negative nodal status), but negatively with the expression of Her2/neu and the proliferation marker Ki67. In contrast, TRAIL-R2 and TRAIL-R4 expression correlated with higher tumour grades, higher Ki67 index, higher Her2/neu expression and a positive nodal status at the time of diagnosis, but with lower expression of Bcl-2. Thus, the TRAIL receptor expression pattern was predictive of nodal status. Patients with grade 1 and 2 tumours, who had TRAIL-R2 but no TRAIL-R1, showed a positive lymph node status in 47% of the cases. Vice versa, only 19% had a positive nodal status with high TRAIL-R1 but low TRAIL-R2. Most strikingly, TRAIL-R4 and -R2 expression negatively correlated with overall survival of breast cancer patients. Although TRAIL-R2 correlated with more aggressive tumour behaviour, mammary carcinoma could be sensitised to TRAIL-R2-induced apoptosis, suggesting that TRAIL-R2 might therefore be used to therapeutically target such tumours. Hence, determination of the TRAIL receptor expression profile may aid in defining which breast cancer patients have a higher risk of lymph node metastasis and worse overall survival and on the other hand will help to guide TRAIL-based tumour therapy.
datePublished:2009-08-13T00:00:00Z
dateModified:2009-08-13T00:00:00Z
pageStart:995
pageEnd:1007
sameAs:https://doi.org/10.1007/s00109-009-0510-z
keywords:
TRAIL receptor
Apoptosis
Prognosis
Breast cancer
Mammary carcinoma
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-009-0510-z/MediaObjects/109_2009_510_Fig6_HTML.gif
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:87
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Tom M. Ganten
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Jaromir Sykora
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ronald Koschny
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Emanuela Batke
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Sebastian Aulmann
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ulrich Mansmann
affiliation:
name:University of München
address:
name:Department of Medical Biometry and Epidemiology, University of München, München, Germany
type:PostalAddress
type:Organization
type:Person
name:Wolfgang Stremmel
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Hans-Peter Sinn
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Henning Walczak
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Imperial College London
address:
name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:87
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
name:University of München
address:
name:Department of Medical Biometry and Epidemiology, University of München, München, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:Imperial College London
address:
name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Tom M. Ganten
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Jaromir Sykora
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Ronald Koschny
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Emanuela Batke
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Sebastian Aulmann
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Ulrich Mansmann
affiliation:
name:University of München
address:
name:Department of Medical Biometry and Epidemiology, University of München, München, Germany
type:PostalAddress
type:Organization
name:Wolfgang Stremmel
affiliation:
name:University Hospital
address:
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Hans-Peter Sinn
affiliation:
name:University Hospital
address:
name:Department of Pathology, University Hospital, Heidelberg, Germany
type:PostalAddress
type:Organization
name:Henning Walczak
affiliation:
name:German Cancer Research Center (DKFZ)
address:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Imperial College London
address:
name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
name:Department of Pathology, University Hospital, Heidelberg, Germany
name:Department of Medical Biometry and Epidemiology, University of München, München, Germany
name:Department of Internal Medicine, University Hospital, Heidelberg, Germany
name:Department of Pathology, University Hospital, Heidelberg, Germany
name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(164)
- How much profit does https://www.springernature.com/gp/authors make?
- Revenue of https://link.springernature.com/home/
- What's the income generated by https://order.springer.com/public/cart each month?
- How much does https://www.editorialmanager.com/jmme gross monthly?
- https://www.springernature.com/gp/librarians/licensing/agc/journals income
- What's the total monthly financial gain of https://doi.org/10.1016%2FS1359-6101%2802%2900006-0?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12486874 bring in each month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=On%20the%20TRAIL%20to%20apoptosis&journal=Cytokine%20Growth%20Factor%20Rev&doi=10.1016%2FS1359-6101%2802%2900006-0&volume=13&pages=199-207&publication_year=2002&author=Baetu%2CTM&author=Hiscott%2CJ?
- Get to know https://doi.org/10.1016%2FS1074-7613%2800%2980400-8's earnings
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9430227?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Death%20receptor%205%2C%20a%20new%20member%20of%20the%20TNFR%20family%2C%20and%20DR4%20induce%20FADD-dependent%20apoptosis%20and%20activate%20the%20NF-kappaB%20pathway&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980400-8&volume=7&pages=821-830&publication_year=1997&author=Chaudhary%2CPM&author=Eby%2CM&author=Jasmin%2CA&author=Bookwalter%2CA&author=Murray%2CJ&author=Hood%2CL?
- How much profit does https://doi.org/10.1126%2Fscience.276.5309.111 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9082980 gross monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20receptor%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=Science&doi=10.1126%2Fscience.276.5309.111&volume=276&pages=111-113&publication_year=1997&author=Pan%2CG&author=O%27Rourke%2CK&author=Chinnaiyan%2CAM&author=Gentz%2CR&author=Ebner%2CR&author=Ni%2CJ make?
- Revenue of https://doi.org/10.1093%2Femboj%2F16.17.5386
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9311998 make?
- How much does http://scholar.google.com/scholar_lookup?&title=TRAIL-R2%3A%20a%20novel%20apoptosis-mediating%20receptor%20for%20TRAIL&journal=EMBO%20J&doi=10.1093%2Femboj%2F16.17.5386&volume=16&pages=5386-5397&publication_year=1997&author=Walczak%2CH&author=Degli-Esposti%2CMA&author=Johnson%2CRS&author=Smolak%2CPJ&author=Waugh%2CJY&author=Boiani%2CN pull in monthly?
- What's the revenue for https://doi.org/10.1016%2FS1074-7613%2800%2980399-4?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9430226
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20novel%20receptor%20TRAIL-R4%20induces%20NF-kappaB%20and%20protects%20against%20TRAIL-mediated%20apoptosis%2C%20yet%20retains%20an%20incomplete%20death%20domain&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980399-4&volume=7&pages=813-820&publication_year=1997&author=Degli-Esposti%2CMA&author=Dougall%2CWC&author=Smolak%2CPJ&author=Waugh%2CJY&author=Smith%2CCA&author=Goodwin%2CRG make?
- What are the total earnings of https://doi.org/10.1084%2Fjem.186.7.1165?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9314565
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Cloning%20and%20characterization%20of%20TRAIL-R3%2C%20a%20novel%20member%20of%20the%20emerging%20TRAIL%20receptor%20family&journal=J%20Exp%20Med&doi=10.1084%2Fjem.186.7.1165&volume=186&pages=1165-1170&publication_year=1997&author=Degli-Esposti%2CMA&author=Smolak%2CPJ&author=Walczak%2CH&author=Waugh%2CJ&author=Huang%2CCP&author=DuBose%2CRF
- Earnings of https://doi.org/10.1126%2Fscience.277.5327.818
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9242611 pull in?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Control%20of%20TRAIL-induced%20apoptosis%20by%20a%20family%20of%20signaling%20and%20decoy%20receptors&journal=Science&doi=10.1126%2Fscience.277.5327.818&volume=277&pages=818-821&publication_year=1997&author=Sheridan%2CJP&author=Marsters%2CSA&author=Pitti%2CRM&author=Gurney%2CA&author=Skubatch%2CM&author=Baldwin%2CD making per month?
- How much profit does https://doi.org/10.1074%2Fjbc.273.23.14363 generate?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9603945
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Osteoprotegerin%20is%20a%20receptor%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.273.23.14363&volume=273&pages=14363-14367&publication_year=1998&author=Emery%2CJG&author=McDonnell%2CP&author=Burke%2CMB&author=Deen%2CKC&author=Lyn%2CS&author=Silverman%2CC?
- How much income is https://doi.org/10.1002%2Fhep.20807 earning monthly?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16037944?
- How much does http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibition%20sensitizes%20hepatocellular%20carcinoma%20cells%2C%20but%20not%20human%20hepatocytes%2C%20to%20TRAIL&journal=Hepatology&doi=10.1002%2Fhep.20807&volume=42&pages=588-597&publication_year=2005&author=Ganten%2CTM&author=Koschny%2CR&author=Haas%2CTL&author=Sykora%2CJ&author=Li-Weber%2CM&author=Herzer%2CK earn?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-05-2635 pull in?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16638878?
- How much money does http://scholar.google.com/scholar_lookup?&title=Preclinical%20differentiation%20between%20apparently%20safe%20and%20potentially%20hepatotoxic%20applications%20of%20TRAIL%20either%20alone%20or%20in%20combination%20with%20chemotherapeutic%20drugs&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2635&volume=12&pages=2640-2646&publication_year=2006&author=Ganten%2CTM&author=Koschny%2CR&author=Sykora%2CJ&author=Schulze-Bergkamen%2CH&author=Buchler%2CP&author=Haas%2CTL generate?
- What are the total earnings of https://doi.org/10.1016%2Fj.cytogfr.2004.12.001?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15733832 earn?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Tumour%20therapeutics%20by%20design%3A%20targeting%20and%20activation%20of%20death%20receptors&journal=Cytokine%20Growth%20Factor%20Rev&doi=10.1016%2Fj.cytogfr.2004.12.001&volume=16&pages=55-76&publication_year=2005&author=Wajant%2CH&author=Gerspach%2CJ&author=Pfizenmaier%2CK
- How much does https://doi.org/10.1158%2F1078-0432.CCR-04-0794 pull in?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15585621 making per month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Partial%20contribution%20of%20tumour%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%2FTRAIL%20receptor%20pathway%20to%20antitumour%20effects%20of%20interferon-alpha%2F5-fluorouracil%20against%20hepatocellular%20carcinoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-0794&volume=10&pages=7884-7895&publication_year=2004&author=Yamamoto%2CT&author=Nagano%2CH&author=Sakon%2CM&author=Wada%2CH&author=Eguchi%2CH&author=Kondo%2CM make?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14606071 each month?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Expression%20of%20TNF-related%20apoptosis-inducing%20ligand%20receptors%20and%20antitumour%20tumour%20effects%20of%20TNF-related%20apoptosis-inducing%20ligand%20in%20human%20hepatocellular%20carcinoma&journal=World%20J%20Gastroenterol&volume=9&pages=2433-2440&publication_year=2003&author=Chen%2CXP&author=He%2CSQ&author=Wang%2CHP&author=Zhao%2CYZ&author=Zhang%2CWG earns monthly
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12473583 have monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Expression%20of%20TRAIL%20and%20TRAIL%20receptors%20in%20colon%20carcinoma%3A%20TRAIL-R1%20is%20an%20independent%20prognostic%20parameter&journal=Clin%20Cancer%20Res&volume=8&pages=3734-3740&publication_year=2002&author=Strater%2CJ&author=Hinz%2CU&author=Walczak%2CH&author=Mechtersheimer%2CG&author=Koretz%2CK&author=Herfarth%2CC earning monthly?
- How much money does https://doi.org/10.1002%2Fpath.1364 generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12845629 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20TRAIL%20%28TNF-related%20apoptosis-inducing%20ligand%29%20and%20its%20receptors%20in%20normal%20colonic%20mucosa%2C%20adenomas%2C%20and%20carcinomas&journal=J%20Pathol&doi=10.1002%2Fpath.1364&volume=200&pages=327-335&publication_year=2003&author=Koornstra%2CJJ&author=Kleibeuker%2CJH&author=Geelen%2CCM&author=Rijcken%2CFE&author=Hollema%2CH&author=Vries%2CEG bring in each month?
- Income figures for https://doi.org/10.1097%2F00006676-200110000-00005
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11590320
- How much income is http://scholar.google.com/scholar_lookup?&title=Tumour%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20and%20its%20receptor%20expression%20and%20the%20pathway%20of%20apoptosis%20in%20human%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2F00006676-200110000-00005&volume=23&pages=251-258&publication_year=2001&author=Satoh%2CK&author=Kaneko%2CK&author=Hirota%2CM&author=Masamune%2CA&author=Satoh%2CA&author=Shimosegawa%2CT earning monthly?
- What's the revenue for https://doi.org/10.1016%2FS0304-3835%2800%2900660-1?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11163110
- Find out how much http://scholar.google.com/scholar_lookup?&title=Effects%20and%20expression%20of%20TRAIL%20and%20its%20apoptosis-promoting%20receptors%20in%20human%20pancreatic%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2800%2900660-1&volume=163&pages=71-81&publication_year=2001&author=Ozawa%2CF&author=Friess%2CH&author=Kleeff%2CJ&author=Xu%2CZW&author=Zimmermann%2CA&author=Sheikh%2CMS earns monthly
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11848467?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Differential%20expression%20of%20TRAIL-R3%20and%20TRAIL-R4%20in%20human%20pancreatic%20cancer&journal=Anticancer%20Res&volume=21&pages=3153-3159&publication_year=2001&author=Liao%2CQ&author=Friess%2CH&author=Kleeff%2CJ&author=Buchler%2CMW
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12960128?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20TRAIL%20and%20TRAIL%20death%20receptors%20in%20stage%20III%20non-small%20cell%20lung%20cancer%20tumours&journal=Clin%20Cancer%20Res&volume=9&pages=3397-3405&publication_year=2003&author=Spierings%2CDC&author=Vries%2CEG&author=Timens%2CW&author=Groen%2CHJ&author=Boezen%2CHM&author=Jong%2CS
- What's the income of https://doi.org/10.1002%2Fijc.10694?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12385006 net monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Mutation%20analysis%20and%20mRNA%20expression%20of%20trail-receptors%20in%20human%20breast%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10694&volume=102&pages=117-128&publication_year=2002&author=Seitz%2CS&author=Wassmuth%2CP&author=Fischer%2CJ&author=Nothnagel%2CA&author=Jandrig%2CB&author=Schlag%2CPM makes per month
- What's the profit of https://doi.org/10.1111%2Fj.1365-2559.1991.tb00229.x?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1757079 generate monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Pathological%20prognostic%20factors%20in%20breast%20cancer.%20I.%20The%20value%20of%20histological%20grade%20in%20breast%20cancer%3A%20experience%20from%20a%20large%20study%20with%20long-term%20follow-up&journal=Histopathology&doi=10.1111%2Fj.1365-2559.1991.tb00229.x&volume=19&pages=403-410&publication_year=1991&author=Elston%2CCW&author=Ellis%2CIO
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3303008 pull in monthly?
- What's http://scholar.google.com/scholar_lookup?&title=Recommendation%20for%20uniform%20definition%20of%20an%20immunoreactive%20score%20%28IRS%29%20for%20immunohistochemical%20estrogen%20receptor%20detection%20%28ER-ICA%29%20in%20breast%20cancer%20tissue&journal=Pathologe&volume=8&pages=138-140&publication_year=1987&author=Remmele%2CW&author=Stegner%2CHE's gross income?
- Profit of https://doi.org/10.1002%2Fbimj.200710456
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18932134?
- How much does http://scholar.google.com/scholar_lookup?&title=Multiple%20testing%20with%20minimal%20assumption&journal=Biom%20J&doi=10.1002%2Fbimj.200710456&volume=50&pages=745-755&publication_year=2008&author=Westfall%2CPH&author=Troendle%2CJF rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11801676 pull in?
- http://scholar.google.com/scholar_lookup?&title=Increased%20susceptibility%20to%20tumour%20initiation%20and%20metastasis%20in%20TNF-related%20apoptosis-inducing%20ligand-deficient%20mice&journal=J%20Immunol&volume=168&pages=1356-1361&publication_year=2002&author=Cretney%2CE&author=Takeda%2CK&author=Yagita%2CH&author=Glaccum%2CM&author=Peschon%2CJJ&author=Smyth%2CMJ's financial summary
- See how much https://doi.org/10.1038%2F83416 makes per month
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11135622?
- How much does http://scholar.google.com/scholar_lookup?&title=Involvement%20of%20tumour%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20surveillance%20of%20tumour%20metastasis%20by%20liver%20natural%20killer%20cells&journal=Nat%20Med&doi=10.1038%2F83416&volume=7&pages=94-100&publication_year=2001&author=Takeda%2CK&author=Hayakawa%2CY&author=Smyth%2CMJ&author=Kayagaki%2CN&author=Yamaguchi%2CN&author=Kakuta%2CS make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15024706?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20protein%20in%20normal%2C%20hyperplastic%20and%20neoplastic%20breast%20tissues.%20A%20metabolite%20of%20the%20putative%20stem-cell%20subpopulation%20of%20the%20mammary%20gland&journal=Histol%20Histopathol&volume=19&pages=457-463&publication_year=2004&author=Luna-More%2CS&author=Weil%2CB&author=Bautista%2CD&author=Garrido%2CE&author=Florez%2CP&author=Martinez%2CC generate?
- What's the monthly income of https://doi.org/10.1093%2Femboj%2Fcdf356?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12110583
- How much revenue does http://scholar.google.com/scholar_lookup?&title=c-FLIP%28L%29%20is%20a%20dual%20function%20regulator%20for%20caspase-8%20activation%20and%20CD95-mediated%20apoptosis&journal=EMBO%20J&doi=10.1093%2Femboj%2Fcdf356&volume=21&pages=3704-3714&publication_year=2002&author=Chang%2CDW&author=Xing%2CZ&author=Pan%2CY&author=Algeciras-Schimnich%2CA&author=Barnhart%2CBC&author=Yaish-Ohad%2CS generate?
- What's the financial gain of https://doi.org/10.1002%2Fcncr.11083?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12548595?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Survival%20of%20patients%20with%20metastatic%20breast%20carcinoma%3A%20importance%20of%20prognostic%20markers%20of%20the%20primary%20tumour&journal=Cancer&doi=10.1002%2Fcncr.11083&volume=97&pages=545-553&publication_year=2003&author=Chang%2CJ&author=Clark%2CGM&author=Allred%2CDC&author=Mohsin%2CS&author=Chamness%2CG&author=Elledge%2CRM?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12469156
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20Bcl-2%20in%20invasive%20breast%20cancer%20receiving%20chemotherapy%20and%20endocrine%20therapy&journal=Oncol%20Rep&volume=10&pages=121-125&publication_year=2003&author=Yang%2CQ&author=Sakurai%2CT&author=Yoshimura%2CG&author=Suzuma%2CT&author=Umemura%2CT&author=Nakamura%2CM?
- How profitable is https://doi.org/10.1016%2FS1040-8428%2802%2900144-0?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12633842's earnings
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Primary%20breast%20cancer%20in%20elderly%20women%3A%20biological%20profile%20and%20relation%20with%20clinical%20outcome&journal=Crit%20Rev%20Oncol%20Hematol&doi=10.1016%2FS1040-8428%2802%2900144-0&volume=45&pages=313-325&publication_year=2003&author=Daidone%2CMG&author=Coradini%2CD&author=Martelli%2CG&author=Veneroni%2CS have monthly?
- Get to know https://doi.org/10.1023%2FA%3A1008359722254's earnings
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10847456 bring in?
- http://scholar.google.com/scholar_lookup?&title=P53%20determination%20alongside%20classical%20prognostic%20factors%20in%20node-negative%20breast%20cancer%3A%20an%20evaluation%20at%20more%20than%2010-year%20follow-up&journal=Ann%20Oncol&doi=10.1023%2FA%3A1008359722254&volume=11&pages=393-397&publication_year=2000&author=Ferrero%2CJM&author=Ramaioli%2CA&author=Formento%2CJL&author=Francoual%2CM&author=Etienne%2CMC&author=Peyrottes%2CI income
- Income figures for https://doi.org/10.1038%2Fsj.cdd.4401437
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15105837?
- http://scholar.google.com/scholar_lookup?&title=Enhanced%20caspase-8%20recruitment%20to%20and%20activation%20at%20the%20DISC%20is%20critical%20for%20sensitisation%20of%20human%20hepatocellular%20carcinoma%20cells%20to%20TRAIL-induced%20apoptosis%20by%20chemotherapeutic%20drugs&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4401437&volume=11&issue=Suppl%201&pages=S86-96&publication_year=2004&author=Ganten%2CTM&author=Haas%2CTL&author=Sykora%2CJ&author=Stahl%2CH&author=Sprick%2CMR&author=Fas%2CSC's revenue stream
- Explore the financials of https://doi.org/10.1002%2Fhep.21555
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17326159 bring in each month?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=TRAIL%2FBortezomib%20co-treatment%20is%20hepatotoxic%20but%20induces%20cancer-specific%20apoptosis%20within%20a%20therapeutic%20window&journal=Hepatology&doi=10.1002%2Fhep.21555&volume=45&issue=3&pages=649-658&publication_year=2007&author=Koschny%2CR&author=Ganten%2CTM&author=Sykora%2CJ&author=Haas%2CTL&author=Sprick%2CMR&author=Kolb%2CA is on a monthly basis
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10652623 pull in?
- Profit of http://scholar.google.com/scholar_lookup?&title=Microvessel%20density%2C%20proliferating%20activity%2C%20p53%20and%20bcl-2%20expression%20in%20in%20situ%20ductal%20carcinoma%20of%20the%20breast&journal=Anticancer%20Res&volume=19&pages=3269-3274&publication_year=1999&author=Zolota%2CV&author=Gerokosta%2CA&author=Melachrinou%2CM&author=Kominea%2CA&author=Aletra%2CC&author=Scopa%2CCD
- https://doi.org/10.1136%2Fjcp.2003.010777 income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15220356 gross monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20proliferation%20in%20invasive%20breast%20cancer%3A%20a%20review&journal=J%20Clin%20Pathol&doi=10.1136%2Fjcp.2003.010777&volume=57&pages=675-681&publication_year=2004&author=Diest%2CPJ&author=Wall%2CE&author=Baak%2CJP making per month?
- How much revenue does https://doi.org/10.1053%2Fejso.2000.0943 bring in?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11034803 produce monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Prolactin%20as%20a%20local%20growth%20promoter%20in%20patients%20with%20breast%20cancer%3A%20GCRI%20experience&journal=Eur%20J%20Surg%20Oncol&doi=10.1053%2Fejso.2000.0943&volume=26&pages=540-547&publication_year=2000&author=Bhatavdekar%2CJM&author=Patel%2CDD&author=Shah%2CNG&author=Vora%2CHH&author=Suthar%2CTP&author=Ghosh%2CN
- How much does https://doi.org/10.1016%2FS0002-9610%2802%2901203-5 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12559449 gross monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Prognostic%20significance%20of%20the%20coexpression%20of%20p53%20protein%20and%20c-erbB2%20in%20breast%20cancer&journal=Am%20J%20Surg&doi=10.1016%2FS0002-9610%2802%2901203-5&volume=185&pages=165-167&publication_year=2003&author=Tsutsui%2CS&author=Ohno%2CS&author=Murakami%2CS&author=Kataoka%2CA&author=Kinoshita%2CJ&author=Hachitanda%2CY make?
- How much does https://doi.org/10.1054%2Fbrst.2000.0225 net monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14965564
- How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20HER-2%2Fneu%20and%20p53%20expression%20in%20node-positive%20breast%20cancer.%20HER-2%2Fneu%20effect%20on%20adjuvant%20tamoxifen%20treatment&journal=Breast&doi=10.1054%2Fbrst.2000.0225&volume=10&pages=67-77&publication_year=2001&author=Climent%2CMA&author=Segui%2CMA&author=Peiro%2CG&author=Molina%2CR&author=Lerma%2CE&author=Ojeda%2CB pull in?
- What's the income of https://doi.org/10.1158%2F1078-0432.CCR-05-0158?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16033835?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Evaluating%20the%20expression%20and%20prognostic%20value%20of%20TRAIL-R1%20and%20TRAIL-R2%20in%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0158&volume=11&pages=5188-5194&publication_year=2005&author=McCarthy%2CMM&author=Sznol%2CM&author=DiVito%2CKA&author=Camp%2CRL&author=Rimm%2CDL&author=Kluger%2CHM bring in?
- What's https://doi.org/10.1111%2Fj.1365-2141.2007.06852.x's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17922877 bring in each month?
- Get to know http://scholar.google.com/scholar_lookup?&title=TRAIL%20signals%20to%20apoptosis%20in%20chronic%20lymphocytic%20leukaemia%20cells%20primarily%20through%20TRAIL-R1%20whereas%20cross-linked%20agonistic%20TRAIL-R2%20antibodies%20facilitate%20signalling%20via%20TRAIL-R2&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2007.06852.x&volume=139&pages=568-577&publication_year=2007&author=Natoni%2CA&author=MacFarlane%2CM&author=Inoue%2CS&author=Walewska%2CR&author=Majid%2CA&author=Knee%2CD's earnings
- How much money does https://doi.org/10.1073%2Fpnas.0507329102 generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16319225 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Preligand%20assembly%20domain-mediated%20ligand-independent%20association%20between%20TRAIL%20receptor%204%20%28TR4%29%20and%20TR2%20regulates%20TRAIL-induced%20apoptosis&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.0507329102&volume=102&pages=18099-18104&publication_year=2005&author=Clancy%2CL&author=Mruk%2CK&author=Archer%2CK&author=Woelfel%2CM&author=Mongkolsapaya%2CJ&author=Screaton%2CG generate?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9973225
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20augments%20TRAIL-induced%20apoptosis%20in%20breast%20cell%20lines&journal=Cancer%20Res&volume=59&pages=734-741&publication_year=1999&author=Keane%2CMM&author=Ettenberg%2CSA&author=Nau%2CMM&author=Russell%2CEK&author=Lipkowitz%2CS?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14500373 bring in each month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Synergistic%20interactions%20of%20chemotherapeutic%20drugs%20and%20tumour%20necrosis%20factor-related%20apoptosis-inducing%20ligand%2FApo-2%20ligand%20on%20apoptosis%20and%20on%20regression%20of%20breast%20carcinoma%20in%20vivo&journal=Cancer%20Res&volume=63&pages=5390-5400&publication_year=2003&author=Singh%2CTR&author=Shankar%2CS&author=Chen%2CX&author=Asim%2CM&author=Srivastava%2CRK
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14506165
- http://scholar.google.com/scholar_lookup?&title=Antitumour%20efficacy%20of%20TRA-8%20anti-DR5%20monoclonal%20antibody%20alone%20or%20in%20combination%20with%20chemotherapy%20and%2For%20radiation%20therapy%20in%20a%20human%20breast%20cancer%20model&journal=Clin%20Cancer%20Res&volume=9&pages=3731-3741&publication_year=2003&author=Buchsbaum%2CDJ&author=Zhou%2CT&author=Grizzle%2CWE&author=Oliver%2CPG&author=Hammond%2CCJ&author=Zhang%2CS's revenue stream
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11410508
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Nucleotidec%20substitution%20in%20the%20ectodomain%20of%20trail%20receptor%20dr4%20is%20associated%20with%20lung%20cancer%20and%20head%20and%20neck%20cancer&journal=Clin%20Cancer%20Res&volume=7&pages=1688-1697&publication_year=2001&author=Fisher%2CMJ&author=Virmani%2CAK&author=Wu%2CL&author=Aplenc%2CR&author=Harper%2CJC&author=Powell%2CSM?
- What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/s00109-009-0510-z?format=refman&flavour=references?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tom%20M.%20Ganten?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tom%20M.%20Ganten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jaromir%20Sykora?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jaromir%20Sykora%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ronald%20Koschny
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ronald%20Koschny%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Emanuela%20Batke's total income per month
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Emanuela%20Batke%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sebastian%20Aulmann
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sebastian%20Aulmann%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ulrich%20Mansmann makes per month
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ulrich%20Mansmann%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wolfgang%20Stremmel's financial summary
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wolfgang%20Stremmel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hans-Peter%20Sinn's total income per month
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hans-Peter%20Sinn%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Henning%20Walczak's earnings
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Henning%20Walczak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know https://s100.copyright.com/AppDispatchServlet?title=Prognostic%20significance%20of%20tumour%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20receptor%20expression%20in%20patients%20with%20breast%20cancer&author=Tom%20M.%20Ganten%20et%20al&contentID=10.1007%2Fs00109-009-0510-z©right=Springer-Verlag&publication=0946-2716&publicationDate=2009-08-13&publisherName=SpringerNature&orderBeanReset=true's earnings
- https://citation-needed.springer.com/v2/references/10.1007/s00109-009-0510-z?format=refman&flavour=citation income
- Earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research income
- How much does https://www.springernature.com/gp/products make?
- How much does https://www.springernature.com/gp/librarians pull in?
- How much revenue does https://www.springernature.com/gp/societies produce monthly?
- How much does https://www.springernature.com/gp/partners pull in?
- Get to know what's the income of https://www.springer.com/
- How much does https://www.nature.com/ net monthly?
- What's the monthly income of https://www.biomedcentral.com/?
- What's the financial intake of https://www.palgrave.com/?
- Learn about the earnings of https://www.apress.com/
- How much does https://www.springernature.com/gp/legal/ccpa net monthly?
- Income figures for https://www.springernature.com/gp/info/accessibility
- Profit of https://support.springernature.com/en/support/home
- Check the income stats for https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- What's the monthly income of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref